The deletion of TAMs in the TME or inhibition of CSF1/CSF1R, the main survival ligand/receptor pair secreted by TAMs, significantly enhances the recruitment of CD8+ T cells and induces tumor regression [87] (Figure 3). This evidence concerns the gene CD8A and neoplasm.